Intra-lesional Tumor Boost for Bulky Cervical Cancer

The goal of this clinical trial is to learn if adding a radiation boost (intra-lesional boost) works to treat patients with large-sized cervical cancer. It will also learn about the safety of this treatment. The main questions it aims to answer are: * Does the extra radiation boost effectively reduce the tumor size before the internal radiation (brachytherapy) treatment begins? * What medical problems (side effects) do participants have when receiving this treatment? Researchers will give this intra-lesional boost to all participants during their standard radiation therapy to see if it helps

Trial Details

NCT ID
NCT07435376
Phase
PHASE2
Sponsor
Seoul National University Bundang Hospital
Status
RECRUITING
Cancer Type
Cervical Cancer
Interventions
  • intra-lesional boost IMRT
  • High Dose Rate Brachytherapy
Locations (sample)
  • Seongnam-si, Gyeonggi-do, South Korea|37.43861,127.13778

Key Eligibility Criteria

  • Patients with histologically confirmed squamous cell carcinoma of the cervix.
  • Patients with bulky primary tumor, defined as a tumor volume ≥ 60 cc OR a maximum diameter ≥ 6 cm.
  • Patients aged 19 to 80 years at the time of diagnosis.
  • Patients with an ECOG performance status of 0 to 2.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Cervical Cancer Trials on Trialify →